Wall Street Analysts Think Bicycle Therapeutics (BCYC) Could Surge 85.52%: Read This Before Placing a Bet

Bicycle Therapeutics PLC Sponsored ADR (BCYC) closed the last trading session at $23.48, gaining 4.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 43.56 indicates an 85.5% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $11.61. While the lowest estimate of$ 30 indicates a 27.8% increase from the current price level, the mo ...